| Name | Title | Contact Details |
|---|
Headquartered in Lexington, Kentucky, Alltech has developed a strong global presence in 128 countries. It also has 31 production facilities strategically located throughout the world. We are one of the industry leaders in the animal feed industry, but being a leader brings responsibility. This means that we care about the impact we have on the people and places touched by our mission to improve animal health around the world.
Reviva Labs creates safe, effective natural skin care treatments that produce visible results. It`s why skin care enthusiasts have fallen in love with our skin care over the last 40+ years and why Reviva has become the natural skin care trusted for generations.
Health Resource Solutions is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Information Designs is a Auburn, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.